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ABSTRACT It has been observed previously that plasma
selenium and glutathione levels are subnormal in HIV-
infected individuals, and plasma glutathione peroxidase ac-
tivity is decreased. Under these conditions the survival rate of
AIDS patients is reduced significantly. In the present study,
using 75Se-labeled human Jurkat T cells, we show that the
levels of four 75Se-containing proteins are lower in HIV-
infected cell populations than in uninfected cells. These major
selenoproteins migrated as 57-, 26-, 21-, and 15-kDa species on
SDSyPAGE gels. In our earlier studies, the 57-kDa protein
was purified from T cells and identified as a subunit of
thioredoxin reductase. The 26- and 21-kDa proteins were
identified in immunoblot assays as the glutathione peroxidase
(cGPX or GPX1) subunit and phospholipid hydroperoxide
glutathione peroxidase (PHGPX or GPX4), respectively. We
recently purified the 15-kDa protein and characterized it as a
selenoprotein of unknown function. In contrast to selenopro-
teins, low molecular mass [75Se]compounds accumulated
during HIV infection and migrated as a diffuse band near the
front of SDSyPAGE gels.
Selenium is a trace element that is an essential micronutrient
for many forms of life. It is a natural component of selenium-
dependent enzymes, and in most of these the selenium occurs
in the amino acid selenocysteine (1, 2), which is located in the
catalytic centers of the proteins. There also are a few bacterial
selenium-dependent enzymes that have a dissociable cofactor
form of selenium in the active center instead of selenocysteine
(3, 4). Additionally, there are selenocysteine-containing pro-
teins of unknown function (1, 2), and one of these, selenopro-
tein P, is unusual in that 10 selenocysteine residues are present
in the 43-kDa polypeptide of the glycoprotein (5). Under
conditions of selenium deficiency the levels of selenoproteins
are depressed to varying degrees depending on efficiency of
biosynthesis, relative turnover rates, mRNA stability, enzyme
stability, and many other factors. Their resulting lowered
catalytic and regulatory activities can upset delicate metabolic
balances, lead to cretinism by interfering with normal embry-
onic development (6), and exacerbate numerous diseases such
as prostate, colon, and lung cancer (7) and HIV infection (8).
Dietary supplementation with selenium offers a potentially
effective and inexpensive means of ameliorating these and
many other disorders. In fact, it was reported recently that
there is a direct correlation between a low dietary selenium
intake and a 20-fold increase in risk of developing AIDS in
HIV-infected individuals (8). This negative correlation be-
tween selenium status and progression of AIDS noted in a
number of studies supports a beneficial role of selenium for
HIV-infected individuals. Several hypotheses have been ad-
vanced to explain the effects of selenium on AIDS develop-
ment. Among these are increased expression of antioxidant
selenoproteins (9) and incorporation of selenium by viral
selenoproteins (10). The latter theory predicts that during
HIV infection several viral selenoproteins should be ex-
pressed, either by ribosomal frame shifting andyor by suppres-
sion of termination codons, and synthesis of these viral sel-
enoproteins would deplete the selenium pool of the host. To
determine the biochemical basis of the protective effect of
selenium on the host in HIV infection we have investigated
selenium metabolism in infected and uninfected Jurkat T cells
labeled with 75Se. The results of these studies are reported herein.
MATERIALS AND METHODS
Materials. [75Se]Selenious acid (1,000 Ciymmol) was ob-
tained from the Research Reactor Facility, University of
Missouri (Columbia); precast polyacrylamide gels and molec-
ular weight standards were from NOVEX (San Diego); phos-
phatase substrate immunoblotting system was from Kirkeg-
aard & Perry Laboratories; ECL immunoblotting system was
from Amersham; heat-inactivated fetal bovine serum and
RPMI medium 1640 were from Mediatech (Herndon, VA);
and human glyceraldehyde-3-phosphate dehydrogenase
(GPDH), bovine glutathione peroxidase 1 (GPX1), and poly-
clonal antibodies to human GPDH were from Sigma. Rat liver
GPX1 and rabbit polyclonal antibodies to this protein and to
rat liver thioredoxin were kindly provided by Ho Zoon Chae
and Sue Goo Rhee (National Institutes of Health, Bethesda,
MD). Rabbit polyclonal antibodies to human phospholipid
hydroperoxide GPX (PHGPX) were kindly provided by
Donna Driscoll (Cleveland Clinic Foundation). All other
reagents were of the highest grade available.
Cell Growth and HIV Infection. Infectious HIV-1 was
generated from the molecular clone pNL4–3 by plasmid
transfection of adherent HeLa cells (11). The amount of virus
produced was quantitated by 32P-reverse-transcriptase assay
(in our assays one HIV-1 particle contributes approximately 20
cpm). A human T-cell line, JPX9, (12) was propagated in
RPMI medium 1640 with 10% fetal bovine serum and sodium
[75Se]selenite (2 mCiyml) as described (13). Primary human T
cells were freshly isolated from whole blood and activated by
incubation for 2 days with phytohemagglutinin (750 ngyml) as
described (14) and then incubated an additional 24 hr after
addition of [75Se]selenite. To study the effect of HIV infection
on selenoproteins, JPX9 T cells were infected with HIV-1 for
3 days and then 75Se was added and cultures were incubated an
additional 24 hr. Uninfected cells were incubated in parallel as
controls. Jurkat HIV-infected and uninfected T cells also were
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labeled with 35S by incubation with [35S]methionine and
[35S]cysteine (1 mCi of eachyml) in place of 75Se (15). All cells
were harvested by centrifugation, washed twice with PBS, and
resuspended in reducing SDSyPAGE sample buffer. For in-
fected cells these steps were carried out in virus containment
facilities, and samples were subjected to analyses only after
inactivation of HIV by heating for 5 min at 100°C in sample
buffer. Virus isolation and immunoprecipitations of viral
proteins were performed as described (15, 16).
Nucleic acid fractions from 75Se-labeled HIV-infected and
uninfected cells were prepared by proteinase K digestion (10
mgyml) followed by phenolychloroform (1:1 volyvol) extrac-
tion. The 75Se contents of ethanol-precipitated nucleic acids
were determined with a Beckman 5500 g counter.
Analysis and Distribution of Selenoproteins. SDSyPAGE
analysis was performed according to standard procedures
using 12%, 16%, 18%, or gradient 4–20% polyacrylamide gels.
Gels were stained with Coomassie blue R-250. For detection
and quantification of 75Se in gels, a PhosphorImager (Molec-
ular Dynamics) was used. For separation of Se-containing
proteins, 75Se-labeled cells were mixed with unlabeled cells and
disrupted by sonication in 30 mM TriszHCl, pH 7.5y1 mM
EDTAy2 mM DTTy1 mM phenylmethylsulfonyl f luoride. The
supernatant obtained after centrifugation of the disrupted
cells was applied to a DEAE-Sepharose anion-exchange col-
umn, equilibrated with 30 mM TriszHCl, pH 7.5y2 mM DTTy1
mM EDTA. Proteins were eluted by application of a linear
gradient from 0 to 400 mM NaCl in equilibrating buffer. The
radioactivity of fractions containing 75Se was determined in a
Beckman 5500 g counter, and the peak Se-containing fractions
were analyzed by SDSyPAGE. The fractions corresponding to
the 57-, 26-, 21-, and 15-kDa selenoproteins were purified by
phenyl-Sepharose column chromatography (13). The resulting
phenyl-Sepharose fractions were used for immunoblot assays.
The 26- and 21-kDa GPX proteins, estimated to be 20–40%
enriched by visual inspection of Coomassie blue-stained gels,
were not purified further. Additional purification of the 57-
and 15-kDa proteins (13, 17) resulted in an apparently homo-
geneous preparation of the 57-kDa protein and a 50% pure
preparation of the 15-kDa protein.
Immunoblot Analysis. An immunoblotting procedure with a
phosphatase substrate system was used for the detection of
T-cell GPDH and thioredoxin in crude extracts and for the
detection of partially purified human T-cell GPX1 by poly-
clonal antibodies raised against human GPDH, rat liver thi-
oredoxin, and rat liver GPX1, respectively. Human GPDH and
bovine and rat liver GPX1 served as controls. An immuno-
blotting procedure with an ECL detection system was used to
study the cross reactivity of the T-cell thioredoxin reductase,
the 15-kDa protein, and PHGPX (GPX4) to polyclonal rabbit
antibodies raised against rat liver thioredoxin reductase, the
C-terminal peptide of the human 15-kDa protein, and an
internal peptide of the human GPX4, respectively.
RESULTS AND DISCUSSION
Detection of Selenoproteins in T Cells. Human T cells,
Jurkat JPX9 line, labeled with 75Se during growth in media
supplemented with [75Se]selenite, were subjected to SDSy
PAGE analyses followed by PhosphorImager detection of
labeled proteins. A typical profile of selenium-containing
proteins in these T cells is shown in Fig. 1B, lane 1. It can be
seen that six radiolabeled bands corresponding to masses
ranging from 6 to 57 kDa were separated with the 15-, 21-, 26-,
and 57-kDa protein bands being the most prominent. This
pattern of 75Se-labeled protein bands in the JPX9 cell line
isolated from acute lymphocytic T-cell anemia did not differ
significantly from the profile of 75Se-containing protein bands
detected in activated primary human T cells labeled under
comparable conditions (data not shown).
HIV Infection Affects the Level of Detected Selenoproteins.
Human Jurkat JPX9 cells that were infected with HIV for 3
days and then incubated for an additional 24 hr with 75Se-
labeled selenite showed a marked reduction in 75Se contents of
labeled selenoprotein bands detected in SDSyPAGE gels (Fig.
1B, lane 1) as compared with the corresponding profile of
‘‘mock infected cells’’ [i.e., uninfected cells resuspended ini-
tially in the same buffer with no added virus (Fig. 1B, lane 1)].
The protein bands with decreased 75Se-contents that migrated
as 15-, 21-, 26-, and 57-kDa species correspond to known
selenoproteins (see below). Visual inspection of the numerous
Coomassie blue-stained protein bands in the gels did not reveal
any marked differences in the protein compositions of unin-
FIG. 1. Effect of HIV infection on [75Se]selenoproteins in JPX9 T
cells. HIV-1-infected JPX9 T cells were cultured in parallel with
control uninfected cells, labeled with 75Se, and prepared for SDSy
PAGE analysis as described in Materials and Methods. (A) Coomassie
blue-stained 16% polyacrylamide gel. Lane 1, molecular mass stan-
dards (sizes in kDa on left); lane 2, uninfected cell proteins, and lane
3, infected cell proteins. (B) PhosphorImager detection of 75Se-labeled
protein bands. Lane 1, uninfected cells and lane 2, HIV-infected cells.
Molecular masses of selenoproteins (in kDa) are shown. (C) Immu-
noblot detection of GPDH after 12% SDSyPAGE. Lane 1, human
GPDH standard; lane 2, protein standards; lane 3, infected cell
sample; lane 4, uninfected cell sample. (D) Immunoblot detection of
thioredoxin after 4–20% gradient gel SDSyPAGE. Lanes 1 and 4,
molecular size standards; lanes 2 and 5, infected cell sample; lanes 3
and 6, uninfected cell sample. Lanes 5 and 6, 75Se-labeled proteins in
lanes 2 and 3, respectively, detected by PhosphorImager analysis. Two
immunoreactive bands detected with the antibodies in lanes 2 and 3
indicate the presence of native and truncated species.
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fected and infected T cell populations (Fig. 1 A, lanes 2 and 3).
Likewise, comparison of 35S-labeled proteins from infected
and ‘‘mock-infected’’ JPX9 cells that had been cultured in
media containing [35S]methionine and [35S]cysteine, after sep-
aration by SDSyPAGE and quantification of major radioactive
bands on a PhosphorImager, showed no apparent differences
(data not shown). However, decreases in nonselenium con-
taining proteins during HIV infection might not be detected
because many protein bands from crude cell extracts are
incompletely resolved on SDS gels. GPDH, a tetrameric
enzyme with one essential sulfhydryl group per 44-kDa subunit
at the active center, is sensitive to oxygen inactivation in the
presence of iron and the oxidized enzyme then is susceptible
to proteolysis (18). Thioredoxin is a 12-kDa protein containing
a redox active disulfide center. Examination of GPDH and
thioredoxin in HIV-infected and uninfected T cells by immu-
noblotting revealed no detectable differences in immunoreac-
tive protein levels under these conditions (Fig. 1 C and D),
suggesting that decreases in 75Se-labeled selenoproteins during
HIV-1 infection might be the result of a selective rather than
a generalized process. However, in those experiments in which
only the selenium contents of the selenoprotein bands on the
gels were measured, the actual amount of immunoreactive
protein present is unknown. If loss of selenium from oxidized
selenocysteine residues in the proteins occurs in HIV-infected
cells, then removal of the oxidatively damaged proteins de-
pends on subsequent proteolytic degradation. A relatively
rapid rate of 75Se elimination from selenoproteins, which can
be measured with precision and a slower rate of proteolysis of
inactive oxidized proteins, could account for the observed
results. In a study in which the major oxidatively damaged
proteins in Escherichia coli cells exposed to oxidative stress
were identified (19), there were no apparent differences in
stained protein bands on gels that corresponded to immuno-
detected oxidized proteins with high carbonyl group contents.
Even in iron-supplemented cultures that showed especially
high oxidative damage and loss of enzyme activity there were
no discernable changes in stained protein bands of crude
extracts. Thus, unless inactivated enzyme species subsequently
are degraded by proteolysis, there is little chance of detecting
any changes by visualization of stained protein bands in
SDSyPAGE gels or by the usual immunoblot procedures that
do not distinguish inactivated from active enzymes.
HIV Infection Affects Low Molecular Mass Selenium Com-
pounds. Another observed difference between 75Se-labeled
HIV-infected and uninfected T cells is a significant increase in
the amounts of low molecular mass selenium species detected
as a diffusely radiolabeled band near the gel front (Fig. 1B,
lane 2). This fraction represented about 60–90% of the 75Se in
infected cell extracts whereas in uninfected cell extracts the
selenoproteins that migrated as 15-, 21-, 26-, and 57-kDa bands
accounted for 60–80% of the total 75Se (Fig. 1B, lane 1).
Nucleic acids were isolated from HIV-infected and uninfected
cells after labeling with 75Se as described in Materials and Methods
to detect any selenium-modified tRNA species that might occur
in T cells. Less than 15% of the radioactivity in the extracts was
recovered in the nucleic acid fractions from either infected or
uninfected cells, indicating that most of the low molecular mass
anionic species detected on the SDSyPAGE gels were derived
from other sources. To directly verify that the low molecular mass
selenium species bind to cellular proteins, infected and uninfected
samples were analyzed by nonreducing SDSyPAGE. The rela-
tively greater amount of 75Se detected in protein bands through-
out the gels in the HIV-infected samples (data not shown)
suggested that the low molecular mass selenium species initially
were associated with proteins. Among such compounds are
selenosulfide derivatives of protein thiols or of glutathione-
protein adducts and anionic polyselenide species.
Identification of Thioredoxin Reductase, GPX1, GPX4, and
the 15-kDa Protein as Major T-Cell Selenoproteins. The
supernatant fraction after centrifugation of the sonicated
crude extract from uninfected T cells grown in the presence of
[75Se]selenite was fractionated on a DEAE-Sepharose anion-
exchange column to resolve the radioactive bands shown in Fig.
1. The radioactive protein components were eluted in the NaCl
gradient applied to the column in four successive 75Se-
containing peak fractions (Fig. 2, lanes 5–8). The last two
radioactive peak fractions eluted from the DEAE column
contained the 57- and 15-kDa proteins (Fig. 2, lanes 7 and 8);
these were purified previously from JPX9 cells and identified
as thioredoxin reductase (13) and a 15-kDa selenoprotein of
unknown function (17), respectively. No other [75Se]-
containing proteins with similar migration properties on SDS
gels were detected in DEAE fractions.
The first 75Se-labeled protein fraction eluted from the DEAE
column contained a labeled protein migrating as a 26-kDa species
and the next contained a 21-kDa species (Fig. 2, lanes 5 and 6,
respectively). The 26-kDa protein was identified as GPX1 based
on its comigration in SDS gels with bovine and rat liver cytosolic
GPXs (GPX1) and on its reactivity with anti-rat liver GPX1
polyclonal antibodies (Fig. 3). The smaller 21-kDa 75Se-labeled
protein was identified as GPX4 on the basis of immunoblot assays
FIG. 2. SDSyPAGE analysis of T cell Se-proteins separated by
DEAE-Sepharose chromatography. 75Se-labeled T cells were soni-
cated and centrifuged, and soluble selenoproteins were chromato-
graphed on a DEAE-Sepharose column (see Materials and Methods).
The peak radioactive fractions were analyzed by SDSyPAGE. Lane 1,
sonic extract; lane 2, sedimented pellet; lane 3, supernatant fraction;
lane 4, proteins not retained on DEAE column (flow through frac-
tion); lane 5, 26-kDa protein (eluted with 150 mM NaCl); lane 6,
21-kDa protein (eluted with 200 mM NaCl); lane 7, 57-kDa protein
(eluted with 250 mM NaCl); lane 8, 15-kDa protein (eluted with 350
mM NaCl); lane 9, mass standards. (A) Coomassie blue-stained gel.
(B) PhosphorImager detection of 75Se-labeled proteins in lanes 1–8 of A.
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of partially purified enzyme with rabbit polyclonal antibodies
elicited to human GPX4 (Fig. 3).
Does HIV Encode Viral Selenoproteins? Generation of new
HIV-1 ORFs containing sporadic UGA codons by ribosomal
frame shifting and translation to give novel virus encoded
selenocysteine-containing proteins has been suggested as a
mechanism to explain selenium deficiency in HIV-infected
individuals (10). However, synthesis of HIV-encoded seleno-
proteins in amounts sufficient to deplete the host cell of
selenium should require elevated expression of the frame-shift
mutants, whereas the putative UGA codons that may not be
effectively introduced by this process are a potential limiting
factor. From our studies, it appears that if any HIV-encoded
selenoproteins are expressed they are produced in amounts too
low to be detected by radiolabeling and therefore the possi-
bility that the host selenium supply is sequestered in viral
proteins is highly unlikely. A comparison of lanes 1 and 2 in Fig.
1B shows no discrete 75Se-labeled protein bands present
exclusively in infected cells. An unidentified slower migrating
faint band in lane 2 may be aggregated protein. We attempted
to isolate 75Se-labeled HIV and to immunoprecipitate putative
viral selenoproteins from HIV-infected T cells using hyper-
immune sera from patients to further test the hypothesis.
However, no 75Se-containing material was found in isolated
virions nor was any 75Se label immunoprecipitated specifically
from HIV-infected cells (data not shown). These results clearly
indicate that selenium deficiency in HIV-infected individuals
cannot be attributed to selective utilization of the selenium
pool for viral selenoprotein synthesis.
To date there is only one example of a virus-encoded seleno-
protein, which is a GPX from Molluscum contagiosum, a specific
human pox virus that causes skin lesions and compromises the
immune system. The viral GPX gene exhibits 80% homology to
human GPX1 and when expressed in HeLa cells it conferred
protection against H2O2 and UV damage (20). The possibility
that the viral gene is of human origin is considered likely.
Is There an Effect of Viral Tat Protein on Levels of
75Se-Labeled Proteins in T Cells? The HIV-1 tat gene encodes
a 12-kDa nuclear protein, Tat, which is secreted by HIV-1
infected cells and this protein can be taken up by noninfected
cells (21). In addition to its role as a transcriptional transac-
tivator of the long terminal repeat region of HIV-1, Tat has
been reported to inhibit the proliferation of antigen-specific T
lymphocytes (22) and to induce apoptosis in these cells (23). A
T-cell line that was stably transfected with the HIV-1 tat gene
showed the characteristic DNA fragmentation pattern of
apoptosis. The extent of apoptosis was markedly greater in
cells that were grown in serum-deficient media as compared
with cells cultured in the presence of adequate growth factors
supplied as 10% fetal calf serum. Selenium, known to be one
of the essential factors for cell growth supplied by the fetal calf
serum, was not tested directly for a possible role in apoptosis
in this study. Speculation as to a possible relationship of HIV
Tat to selenium metabolism was based on a recent report that
the human protein that recognizes the selenocysteine insertion
sequence (SECIS) in selenoprotein mRNAs and HIV Tat
contain similar predicted arginine-rich domains (24). These
homologous domains comprise the predicted amino acid res-
idues 51–67 of HIV-1 Tat and residues 241–256 of the human
SECIS-binding protein (originally designated as DNA-binding
protein B, dbnB). The human protein specifically binds to the
stem-loop structure of the SECIS element in the nontranslated
region of human GPX1 mRNA and in so doing allows UGA
in the ORF to be translated as selenocysteine instead of
termination. The arginine-rich region comprising residues
51–67 of the HIV-1 Tat protein is essential for binding to the
FIG. 3. Immunoblotting and imaging of GPX1 and PHGPX. Lanes
1 and 5, partially purified 75Se-labeled human T-cell GPX1; lanes 2, 6,
and 9, partially purified 75Se-labeled human T-cell PHGPX; lanes 3
and 7, rat liver GPX1; lanes 4 and 8, bovine GPX1. Lanes 1–4,
immunoblot assay with anti-GPX (GPX1) antibodies; lanes 5–8,
PhosphorImaging of the immunoblot shown in lanes 1–4; lane 9,
immunoblot detection with the anti-PHGPX antibodies. The locations
of GPX1 and PHGPX (GPX4) are shown on the left.
FIG. 4. Effect of treatment of Jurkat T cells with Tat protein on levels
of 75Se-labeled proteins. SDSy12% gel PAGE analysis of extracts of
Tat-treated and untreated T cells incubated with 75Se032- for 28 and 50 hr.
Size of the aliquot and amount of radioactivity applied to each well from
the indicated cell extract are as follows: 28 hr, control cells (5,000 cpmy10
ml), lane 2, 10 ml and lane 3, 15 ml; 28 hr, Tat-treated cells (17,000 cpmy10
ml) lane 6, 5 ml and lane 7, 10 ml; 50 hr, control cells (20,000 cpmy10 ml),
lane 4, 5 ml and lane 5, 10 ml; 50 hr, Tat-treated cells (47,500 cpmy10 ml),
lane 8, 4 ml, lane 9, 8 ml, and lane 10, 10 ml.





Total 75Se presenty0.6 ml of extract
Control T cells, Tat-treated T cells,
cpm 3 106 % cpm 3 106 %
28 0.3 0.5 1.02 1.73
50 1.2 2.05 2.85 4.85
Jurkat T cells were propagated in 6-ml cultures containing RPMI
medium 1640 with 10% fetal bovine serum and either maltose-binding
protein (42 kDa), 10 mg, (controls) or maltose-binding-Tat fusion protein
(52 kDa), 10 mg, (Tat-treated cells) for 24 or 48 hr at 37°C in a CO2
incubator. Then 58.8 3 106 cpm 75SeO322 (ca. 3 nmoles; Los Alamos
National Laboratory, NM) were added to each 6-ml culture and incuba-
tion was continued for 28 hr (24-hr culture) or 50 hr (48-hr culture). Cells
were harvested, washed twice, and suspended in SDSyPAGE sample
buffer with mercaptoethanol as described in Materials and Methods.
Extracts (0.6 ml) were heated at 100°C for 10 min.
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TAR element, also a putative stem-loop structure found at the
59 ends of all nascent HIV-1 transcripts. Whether the similarity
of these two arginine-rich regions of HIV-1 Tat and SECIS-
binding protein is sufficient to cause interference in recogni-
tion of their respective stem-loop structures is not known.
However, the SECIS-binding protein from COS-1 cells did not
recognize the HIV-1 TAR element in gel retardation assays (25).
To examine directly a possible relationship of viral Tat
protein to the observed decreased levels of selenoproteins in
HIV-infected T cells, Jurkat T cells first were cultured in media
containing added Tat protein and then allowed to grow further
after 75Se supplementation. The amount of 75Se present in the
SDS extracts of T cells that had been treated initially with Tat
protein was more than double the amount present in the
corresponding control cell extracts (Table 1). However, com-
parison of the distribution of radioactivity in protein bands in
gels revealed that the major selenoproteins from Tat-treated
cells contained a much lower percentage of the total 75Se
applied to each gel lane than the corresponding selenoproteins
from control cells (Fig. 4 and Table 2). The relative amount of
75Se that either migrated off the gel or appeared as three
diffuse bands at the front appeared greater in the case of the
Tat-treated cells, but exact amounts were not measured. These
effects on 75Se distribution in T-cell extracts resulting from
treatment of T cells with Tat protein alone thus mimic to some
degree the decreased levels of 75Se-labeled selenoproteins and
the higher amounts of low molecular mass compounds found
in HIV-infected T cells. In the case of the Tat protein-treated
T-cells, a fixed amount of a Tat fusion protein (10 mg) was
added at the start to each 6-ml culture whereas in HIV-
infected cells Tat protein presumably is synthesized and ex-
creted into the medium throughout the growth period. If cells
undergo apoptosis during the period of incubation with 75Se
and under these conditions there is rapid loss of reduced
glutathione as has been reported for Jurkat T cells induced to
undergo apoptosis by treatment with anti-FasyAPO-1 anti-
body (26), then oxidative stress conditions induced by the
lowered glutathione levels would lead to nonreversible oxida-
tion and elimination of selenium from oxygen labile seleno-
cysteine residues in thioredoxin reductase (27), GPXs, and
other selenoenzymes, which could not be regenerated effi-
ciently to their active selenol forms.
Another explanation for our data is that oxidative stress,
which is known to be characteristic of HIV infection, could
result in decreased amounts of selenophosphate, the oxygen-
labile highly reactive selenium donor compound, that is re-
quired for selenocysteyl-tRNASec formation. In this case,
biosynthesis of specific selenoenzymes would be inhibited
because of lack of the required selenocysteine precursor
whereas synthesis of nonselenoproteins might be relatively
unaffected. Alternatively, if the HIV-1-encoded Tat protein
andyor the TAR stem-loop structure indeed can interfere with
selenoprotein synthesis in infected T cells, then decreased
levels of 75Se-labeled proteins could be expected.
In the studies reported here, both with HIV-1-infected and
with Tat-treated T cells, only the 75Se contents of protein bands
on gels were measured and protein concentrations were not
determined. Because the levels of the major selenoenzymes in
T cells generally are low, especially sensitive immunoblotting
procedures are needed for reliable quantitation in crude
extracts and for calculation of specific radioactivity values.
Although the presence of low selenium content proteins would
suggest that elimination of selenium had occurred subsequent
to oxidative damage, decreased levels of normal selenium
content selenoproteins could be indicative of suppression of
selenoenzyme biosynthesis. Detailed investigation of the ef-
fects of Tat protein on T cell selenium metabolism may serve
to distinguish these possibilities and provide further clues
concerning the pathogenicity of HIV-1.
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Table 2. Effect of Tat protein treatment on 75Se content of
individual selenoproteins
Selenoprotein
75Se content of protein band,
arbitrary density units
Control T cells Tat-treated T cells
Thioredoxin reductase
(57-kDa band) 1,572 1,304
GPX4 (21-kDa band) 975 598
15-kDa proteins (2 bands) 1,766 1,095
The proteins from control T cells and Tat-treated T cells, incubated
50 hr with 75Se, are shown in lanes 5 and 10, respectively, of Fig. 4.
Aliquots (10 ml) applied to the gel contained 20,000 cpm for the
control cell extracat and 47,500 cpm for the Tat-treated cell extract.
The arbitrary density units are not directly convertable to cpm 75Se.
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